1 |
CA5B
| 2件: Nitrogen metabolism Nitrogen metabolism 💬, Metabolic pathways 💬 | D00218
D00218
|
Acetazolamide
| 8件: 13 13, 86, 90, 115, 154, 155, 225, 230 |
2 |
CA5B
| 2件: Nitrogen metabolism Nitrogen metabolism 💬, Metabolic pathways 💬 | D00653
D00653
|
Dorzolamide
| 1件: 90 90 |
3 |
CA5B
| 2件: Nitrogen metabolism Nitrogen metabolism 💬, Metabolic pathways 💬 | D01196
D01196
|
Acetazolamide
| 8件: 13 13, 86, 90, 115, 154, 155, 225, 230 |
4 |
CA5B
| 2件: Nitrogen metabolism Nitrogen metabolism 💬, Metabolic pathways 💬 | D07871
D07871
|
Dorzolamide
| 1件: 90 90 |
5 |
ADRA2A
| 2件: cGMP-PKG signaling pathway cGMP-PKG signaling pathway 💬, Neuroactive ligand-receptor interaction 💬 | D02076
D02076
|
Brimonidine
| 2件: 13 13, 90 |
6 |
ADRA2A
| 2件: cGMP-PKG signaling pathway cGMP-PKG signaling pathway 💬, Neuroactive ligand-receptor interaction 💬 | D07540
D07540
|
Brimonidine
| 2件: 13 13, 90 |
7 |
ADRA2B
| 2件: cGMP-PKG signaling pathway cGMP-PKG signaling pathway 💬, Neuroactive ligand-receptor interaction 💬 | D02076
D02076
|
Brimonidine
| 2件: 13 13, 90 |
8 |
ADRA2B
| 2件: cGMP-PKG signaling pathway cGMP-PKG signaling pathway 💬, Neuroactive ligand-receptor interaction 💬 | D07540
D07540
|
Brimonidine
| 2件: 13 13, 90 |
9 |
ADRA2C
| 2件: cGMP-PKG signaling pathway cGMP-PKG signaling pathway 💬, Neuroactive ligand-receptor interaction 💬 | D02076
D02076
|
Brimonidine
| 2件: 13 13, 90 |
10 |
ADRA2C
| 2件: cGMP-PKG signaling pathway cGMP-PKG signaling pathway 💬, Neuroactive ligand-receptor interaction 💬 | D07540
D07540
|
Brimonidine
| 2件: 13 13, 90 |
11 |
DDC
| 9件: Tyrosine metabolism Tyrosine metabolism 💬, Phenylalanine metabolism 💬, Tryptophan metabolism 💬, Metabolic pathways 💬, Serotonergic synapse 💬, Dopaminergic synapse 💬, Cocaine addiction 💬, Amphetamine addiction 💬, Alcoholism 💬 | D00558
D00558
|
Carbidopa
| 9件: 2 2, 4, 6, 13, 17, 90, 140, 164, 201 |
12 |
DRD1
| 10件: Calcium signaling pathway Calcium signaling pathway 💬, cAMP signaling pathway 💬, Neuroactive ligand-receptor interaction 💬, Gap junction 💬, Dopaminergic synapse 💬, Parkinson disease 💬, Cocaine addiction 💬, Amphetamine addiction 💬, Morphine addiction 💬, Alcoholism 💬 | D00059
D00059
|
Levodopa
| 8件: 2 2, 4, 6, 17, 90, 140, 164, 201 |
13 |
DRD2
| 8件: Rap1 signaling pathway Rap1 signaling pathway 💬, cAMP signaling pathway 💬, Neuroactive ligand-receptor interaction 💬, Gap junction 💬, Dopaminergic synapse 💬, Parkinson disease 💬, Cocaine addiction 💬, Alcoholism 💬 | D00059
D00059
|
Levodopa
| 8件: 2 2, 4, 6, 17, 90, 140, 164, 201 |
14 |
DRD3
| 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬, Dopaminergic synapse 💬 | D00059
D00059
|
Levodopa
| 8件: 2 2, 4, 6, 17, 90, 140, 164, 201 |
15 |
DRD4
| 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬, Dopaminergic synapse 💬 | D00059
D00059
|
Levodopa
| 8件: 2 2, 4, 6, 17, 90, 140, 164, 201 |
16 |
DRD5
| 4件: Calcium signaling pathway Calcium signaling pathway 💬, cAMP signaling pathway 💬, Neuroactive ligand-receptor interaction 💬, Dopaminergic synapse 💬 | D00059
D00059
|
Levodopa
| 8件: 2 2, 4, 6, 17, 90, 140, 164, 201 |
17 |
ABAT
| 7件: Alanine, aspartate and glutamate metabolism Alanine, aspartate and glutamate metabolism 💬, Valine, leucine and isoleucine degradation 💬, beta-Alanine metabolism 💬, Propanoate metabolism 💬, Butanoate metabolism 💬, Metabolic pathways 💬, GABAergic synapse 💬 | D00399
D00399
|
Valproic acid
| 17件: 2 2, 3, 5, 6, 13, 26, 34, 65, 85, 89, 90, 102, 127, 222, 233, 256, 331 |
18 |
CA14
| 2件: Nitrogen metabolism Nitrogen metabolism 💬, Metabolic pathways 💬 | D00218
D00218
|
Acetazolamide
| 8件: 13 13, 86, 90, 115, 154, 155, 225, 230 |
19 |
CA14
| 2件: Nitrogen metabolism Nitrogen metabolism 💬, Metabolic pathways 💬 | D00653
D00653
|
Dorzolamide
| 1件: 90 90 |
20 |
CA14
| 2件: Nitrogen metabolism Nitrogen metabolism 💬, Metabolic pathways 💬 | D01196
D01196
|
Acetazolamide
| 8件: 13 13, 86, 90, 115, 154, 155, 225, 230 |
21 |
CA14
| 2件: Nitrogen metabolism Nitrogen metabolism 💬, Metabolic pathways 💬 | D07871
D07871
|
Dorzolamide
| 1件: 90 90 |
22 |
GAD1
| 7件: Alanine, aspartate and glutamate metabolism Alanine, aspartate and glutamate metabolism 💬, beta-Alanine metabolism 💬, Taurine and hypotaurine metabolism 💬, Butanoate metabolism 💬, Metabolic pathways 💬, GABAergic synapse 💬, Type I diabetes mellitus 💬 | D00399
D00399
|
Valproic acid
| 17件: 2 2, 3, 5, 6, 13, 26, 34, 65, 85, 89, 90, 102, 127, 222, 233, 256, 331 |
23 |
GAD2
| 7件: Alanine, aspartate and glutamate metabolism Alanine, aspartate and glutamate metabolism 💬, beta-Alanine metabolism 💬, Taurine and hypotaurine metabolism 💬, Butanoate metabolism 💬, Metabolic pathways 💬, GABAergic synapse 💬, Type I diabetes mellitus 💬 | D00399
D00399
|
Valproic acid
| 17件: 2 2, 3, 5, 6, 13, 26, 34, 65, 85, 89, 90, 102, 127, 222, 233, 256, 331 |
24 |
NR3C1
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | D00244
D00244
|
Betamethasone
| 3件: 90 90, 96, 235 |
25 |
NR3C1
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | D00292
D00292
|
Dexamethasone
| 10件: 90 90, 96, 97, 162, 222, 235, 257, 283, 296, 299 |
26 |
NR3C1
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | D00385
D00385
|
Triamcinolone
| 6件: 90 90, 96, 107, 162, 226, 298 |
27 |
NR3C1
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | D00972
D00972
|
Betamethasone
| 3件: 90 90, 96, 235 |
28 |
NR3C1
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | D00975
D00975
|
Dexamethasone
| 10件: 90 90, 96, 97, 162, 222, 235, 257, 283, 296, 299 |
29 |
NR3C1
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | D00983
D00983
|
Triamcinolone
| 6件: 90 90, 96, 107, 162, 226, 298 |
30 |
NR3C1
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | D00984
D00984
|
Triamcinolone
| 6件: 90 90, 96, 107, 162, 226, 298 |
31 |
NR3C1
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | D00985
D00985
|
Triamcinolone
| 6件: 90 90, 96, 107, 162, 226, 298 |
32 |
NR3C1
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | D01357
D01357
|
Betamethasone
| 3件: 90 90, 96, 235 |
33 |
NR3C1
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | D01402
D01402
|
Betamethasone
| 3件: 90 90, 96, 235 |
34 |
NR3C1
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | D01510
D01510
|
Dexamethasone
| 10件: 90 90, 96, 97, 162, 222, 235, 257, 283, 296, 299 |
35 |
NR3C1
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | D01615
D01615
|
Dexamethasone
| 10件: 90 90, 96, 97, 162, 222, 235, 257, 283, 296, 299 |
36 |
NR3C1
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | D01632
D01632
|
Dexamethasone
| 10件: 90 90, 96, 97, 162, 222, 235, 257, 283, 296, 299 |
37 |
NR3C1
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | D01637
D01637
|
Betamethasone
| 3件: 90 90, 96, 235 |
38 |
NR3C1
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | D01825
D01825
|
Fluocinolone acetonide
| 1件: 90 90 |
39 |
NR3C1
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | D01948
D01948
|
Dexamethasone
| 10件: 90 90, 96, 97, 162, 222, 235, 257, 283, 296, 299 |
40 |
NR3C1
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | D02032
D02032
|
Betamethasone
| 3件: 90 90, 96, 235 |
41 |
NR3C1
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | D02174
D02174
|
Dexamethasone
| 10件: 90 90, 96, 97, 162, 222, 235, 257, 283, 296, 299 |
42 |
NR3C1
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | D02286
D02286
|
Betamethasone
| 3件: 90 90, 96, 235 |
43 |
NR3C1
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | D02591
D02591
|
Dexamethasone
| 10件: 90 90, 96, 97, 162, 222, 235, 257, 283, 296, 299 |
44 |
NR3C1
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | D02592
D02592
|
Dexamethasone
| 10件: 90 90, 96, 97, 162, 222, 235, 257, 283, 296, 299 |
45 |
NR3C1
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | D06216
D06216
|
Triamcinolone
| 6件: 90 90, 96, 107, 162, 226, 298 |
46 |
CA13
| 2件: Nitrogen metabolism Nitrogen metabolism 💬, Metabolic pathways 💬 | D00218
D00218
|
Acetazolamide
| 8件: 13 13, 86, 90, 115, 154, 155, 225, 230 |
47 |
CA13
| 2件: Nitrogen metabolism Nitrogen metabolism 💬, Metabolic pathways 💬 | D00653
D00653
|
Dorzolamide
| 1件: 90 90 |
48 |
CA13
| 2件: Nitrogen metabolism Nitrogen metabolism 💬, Metabolic pathways 💬 | D01196
D01196
|
Acetazolamide
| 8件: 13 13, 86, 90, 115, 154, 155, 225, 230 |
49 |
CA13
| 2件: Nitrogen metabolism Nitrogen metabolism 💬, Metabolic pathways 💬 | D07871
D07871
|
Dorzolamide
| 1件: 90 90 |
50 |
MTNR1A
| 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬, Circadian entrainment 💬 | D08170
D08170
|
Melatonin
| 12件: 6 6, 8, 13, 37, 46, 49, 90, 97, 144, 145, 149, 202 |
51 |
MTNR1B
| 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬, Circadian entrainment 💬 | D08170
D08170
|
Melatonin
| 12件: 6 6, 8, 13, 37, 46, 49, 90, 97, 144, 145, 149, 202 |
52 |
NGFR
| 8件: MAPK signaling pathway MAPK signaling pathway 💬, Ras signaling pathway 💬, Rap1 signaling pathway 💬, Cytokine-cytokine receptor interaction 💬, PI3K-Akt signaling pathway 💬, Apoptosis - multiple species 💬, Neurotrophin signaling pathway 💬, Transcriptional misregulation in cancer 💬 | D11028
D11028
|
Cenegermin
| 2件: 53 53, 90 |
53 |
PGF
| 6件: MAPK signaling pathway MAPK signaling pathway 💬, Ras signaling pathway 💬, Rap1 signaling pathway 💬, PI3K-Akt signaling pathway 💬, Focal adhesion 💬, Pathways in cancer 💬 | D09574
D09574
|
Aflibercept
| 2件: 90 90, 166 |
54 |
PPP3CA
| 33件: MAPK signaling pathway MAPK signaling pathway 💬, Calcium signaling pathway 💬, cGMP-PKG signaling pathway 💬, Oocyte meiosis 💬, Cellular senescence 💬, Wnt signaling pathway 💬, Axon guidance 💬, VEGF signaling pathway 💬, Osteoclast differentiation 💬, C-type lectin receptor signaling pathway 💬, Natural killer cell mediated cytotoxicity 💬, Th1 and Th2 cell differentiation 💬, Th17 cell differentiation 💬, T cell receptor signaling pathway 💬, B cell receptor signaling pathway 💬, Long-term potentiation 💬, Glutamatergic synapse 💬, Dopaminergic synapse 💬, Oxytocin signaling pathway 💬, Glucagon signaling pathway 💬, Renin secretion 💬, Alzheimer disease 💬, Amyotrophic lateral sclerosis 💬, Prion disease 💬, Pathways of neurodegeneration - multiple diseases 💬, Amphetamine addiction 💬, Tuberculosis 💬, Human cytomegalovirus infection 💬, Human T-cell leukemia virus 1 infection 💬, Kaposi sarcoma-associated herpesvirus infection 💬, Human immunodeficiency virus 1 infection 💬, PD-L1 expression and PD-1 checkpoint pathway in cancer 💬, Lipid and atherosclerosis 💬 | D00184
D00184
|
Cyclosporine
| 44件: 11 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 107, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
55 |
PPP3CB
| 33件: MAPK signaling pathway MAPK signaling pathway 💬, Calcium signaling pathway 💬, cGMP-PKG signaling pathway 💬, Oocyte meiosis 💬, Cellular senescence 💬, Wnt signaling pathway 💬, Axon guidance 💬, VEGF signaling pathway 💬, Osteoclast differentiation 💬, C-type lectin receptor signaling pathway 💬, Natural killer cell mediated cytotoxicity 💬, Th1 and Th2 cell differentiation 💬, Th17 cell differentiation 💬, T cell receptor signaling pathway 💬, B cell receptor signaling pathway 💬, Long-term potentiation 💬, Glutamatergic synapse 💬, Dopaminergic synapse 💬, Oxytocin signaling pathway 💬, Glucagon signaling pathway 💬, Renin secretion 💬, Alzheimer disease 💬, Amyotrophic lateral sclerosis 💬, Prion disease 💬, Pathways of neurodegeneration - multiple diseases 💬, Amphetamine addiction 💬, Tuberculosis 💬, Human cytomegalovirus infection 💬, Human T-cell leukemia virus 1 infection 💬, Kaposi sarcoma-associated herpesvirus infection 💬, Human immunodeficiency virus 1 infection 💬, PD-L1 expression and PD-1 checkpoint pathway in cancer 💬, Lipid and atherosclerosis 💬 | D00184
D00184
|
Cyclosporine
| 44件: 11 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 107, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
56 |
PPP3CC
| 33件: MAPK signaling pathway MAPK signaling pathway 💬, Calcium signaling pathway 💬, cGMP-PKG signaling pathway 💬, Oocyte meiosis 💬, Cellular senescence 💬, Wnt signaling pathway 💬, Axon guidance 💬, VEGF signaling pathway 💬, Osteoclast differentiation 💬, C-type lectin receptor signaling pathway 💬, Natural killer cell mediated cytotoxicity 💬, Th1 and Th2 cell differentiation 💬, Th17 cell differentiation 💬, T cell receptor signaling pathway 💬, B cell receptor signaling pathway 💬, Long-term potentiation 💬, Glutamatergic synapse 💬, Dopaminergic synapse 💬, Oxytocin signaling pathway 💬, Glucagon signaling pathway 💬, Renin secretion 💬, Alzheimer disease 💬, Amyotrophic lateral sclerosis 💬, Prion disease 💬, Pathways of neurodegeneration - multiple diseases 💬, Amphetamine addiction 💬, Tuberculosis 💬, Human cytomegalovirus infection 💬, Human T-cell leukemia virus 1 infection 💬, Kaposi sarcoma-associated herpesvirus infection 💬, Human immunodeficiency virus 1 infection 💬, PD-L1 expression and PD-1 checkpoint pathway in cancer 💬, Lipid and atherosclerosis 💬 | D00184
D00184
|
Cyclosporine
| 44件: 11 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 107, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
57 |
PPP3R1
| 32件: MAPK signaling pathway MAPK signaling pathway 💬, Calcium signaling pathway 💬, cGMP-PKG signaling pathway 💬, Oocyte meiosis 💬, Cellular senescence 💬, Wnt signaling pathway 💬, Axon guidance 💬, VEGF signaling pathway 💬, Osteoclast differentiation 💬, C-type lectin receptor signaling pathway 💬, Natural killer cell mediated cytotoxicity 💬, Th1 and Th2 cell differentiation 💬, Th17 cell differentiation 💬, T cell receptor signaling pathway 💬, B cell receptor signaling pathway 💬, Long-term potentiation 💬, Glutamatergic synapse 💬, Oxytocin signaling pathway 💬, Glucagon signaling pathway 💬, Renin secretion 💬, Alzheimer disease 💬, Amyotrophic lateral sclerosis 💬, Prion disease 💬, Pathways of neurodegeneration - multiple diseases 💬, Amphetamine addiction 💬, Tuberculosis 💬, Human cytomegalovirus infection 💬, Human T-cell leukemia virus 1 infection 💬, Kaposi sarcoma-associated herpesvirus infection 💬, Human immunodeficiency virus 1 infection 💬, PD-L1 expression and PD-1 checkpoint pathway in cancer 💬, Lipid and atherosclerosis 💬 | D00184
D00184
|
Cyclosporine
| 44件: 11 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 107, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
58 |
PPP3R2
| 32件: MAPK signaling pathway MAPK signaling pathway 💬, Calcium signaling pathway 💬, cGMP-PKG signaling pathway 💬, Oocyte meiosis 💬, Cellular senescence 💬, Wnt signaling pathway 💬, Axon guidance 💬, VEGF signaling pathway 💬, Osteoclast differentiation 💬, C-type lectin receptor signaling pathway 💬, Natural killer cell mediated cytotoxicity 💬, Th1 and Th2 cell differentiation 💬, Th17 cell differentiation 💬, T cell receptor signaling pathway 💬, B cell receptor signaling pathway 💬, Long-term potentiation 💬, Glutamatergic synapse 💬, Oxytocin signaling pathway 💬, Glucagon signaling pathway 💬, Renin secretion 💬, Alzheimer disease 💬, Amyotrophic lateral sclerosis 💬, Prion disease 💬, Pathways of neurodegeneration - multiple diseases 💬, Amphetamine addiction 💬, Tuberculosis 💬, Human cytomegalovirus infection 💬, Human T-cell leukemia virus 1 infection 💬, Kaposi sarcoma-associated herpesvirus infection 💬, Human immunodeficiency virus 1 infection 💬, PD-L1 expression and PD-1 checkpoint pathway in cancer 💬, Lipid and atherosclerosis 💬 | D00184
D00184
|
Cyclosporine
| 44件: 11 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 107, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
59 |
PTGFR
| 3件: Calcium signaling pathway Calcium signaling pathway 💬, Phospholipase D signaling pathway 💬, Neuroactive ligand-receptor interaction 💬 | D08661
D08661
|
Unoprostone
| 1件: 90 90 |
60 |
RARA
| 5件: Th17 cell differentiation Th17 cell differentiation 💬, Estrogen signaling pathway 💬, Pathways in cancer 💬, Transcriptional misregulation in cancer 💬, Acute myeloid leukemia 💬 | D06543
D06543
|
Vitamin A
| 3件: 13 13, 53, 90 |
61 |
RARB
| 4件: Pathways in cancer Pathways in cancer 💬, Small cell lung cancer 💬, Non-small cell lung cancer 💬, Gastric cancer 💬 | D06543
D06543
|
Vitamin A
| 3件: 13 13, 53, 90 |
62 |
VEGFA
| 24件: EGFR tyrosine kinase inhibitor resistance EGFR tyrosine kinase inhibitor resistance 💬, MAPK signaling pathway 💬, Ras signaling pathway 💬, Rap1 signaling pathway 💬, Calcium signaling pathway 💬, HIF-1 signaling pathway 💬, PI3K-Akt signaling pathway 💬, VEGF signaling pathway 💬, Focal adhesion 💬, Relaxin signaling pathway 💬, AGE-RAGE signaling pathway in diabetic complications 💬, Human cytomegalovirus infection 💬, Human papillomavirus infection 💬, Kaposi sarcoma-associated herpesvirus infection 💬, Pathways in cancer 💬, Proteoglycans in cancer 💬, MicroRNAs in cancer 💬, Chemical carcinogenesis - receptor activation 💬, Chemical carcinogenesis - reactive oxygen species 💬, Renal cell carcinoma 💬, Pancreatic cancer 💬, Bladder cancer 💬, Rheumatoid arthritis 💬, Fluid shear stress and atherosclerosis 💬 | D09574
D09574
|
Aflibercept
| 2件: 90 90, 166 |
63 |
VEGFB
| 9件: MAPK signaling pathway MAPK signaling pathway 💬, Ras signaling pathway 💬, Rap1 signaling pathway 💬, Calcium signaling pathway 💬, PI3K-Akt signaling pathway 💬, Focal adhesion 💬, Relaxin signaling pathway 💬, AGE-RAGE signaling pathway in diabetic complications 💬, Pathways in cancer 💬 | D09574
D09574
|
Aflibercept
| 2件: 90 90, 166 |
64 |
CA1
| 2件: Nitrogen metabolism Nitrogen metabolism 💬, Metabolic pathways 💬 | D00218
D00218
|
Acetazolamide
| 8件: 13 13, 86, 90, 115, 154, 155, 225, 230 |
65 |
CA1
| 2件: Nitrogen metabolism Nitrogen metabolism 💬, Metabolic pathways 💬 | D00653
D00653
|
Dorzolamide
| 1件: 90 90 |
66 |
CA1
| 2件: Nitrogen metabolism Nitrogen metabolism 💬, Metabolic pathways 💬 | D01196
D01196
|
Acetazolamide
| 8件: 13 13, 86, 90, 115, 154, 155, 225, 230 |
67 |
CA1
| 2件: Nitrogen metabolism Nitrogen metabolism 💬, Metabolic pathways 💬 | D07871
D07871
|
Dorzolamide
| 1件: 90 90 |
68 |
CA2
| 7件: Nitrogen metabolism Nitrogen metabolism 💬, Metabolic pathways 💬, Proximal tubule bicarbonate reclamation 💬, Collecting duct acid secretion 💬, Gastric acid secretion 💬, Pancreatic secretion 💬, Bile secretion 💬 | D00218
D00218
|
Acetazolamide
| 8件: 13 13, 86, 90, 115, 154, 155, 225, 230 |
69 |
CA2
| 7件: Nitrogen metabolism Nitrogen metabolism 💬, Metabolic pathways 💬, Proximal tubule bicarbonate reclamation 💬, Collecting duct acid secretion 💬, Gastric acid secretion 💬, Pancreatic secretion 💬, Bile secretion 💬 | D00653
D00653
|
Dorzolamide
| 1件: 90 90 |
70 |
CA2
| 7件: Nitrogen metabolism Nitrogen metabolism 💬, Metabolic pathways 💬, Proximal tubule bicarbonate reclamation 💬, Collecting duct acid secretion 💬, Gastric acid secretion 💬, Pancreatic secretion 💬, Bile secretion 💬 | D01196
D01196
|
Acetazolamide
| 8件: 13 13, 86, 90, 115, 154, 155, 225, 230 |
71 |
CA2
| 7件: Nitrogen metabolism Nitrogen metabolism 💬, Metabolic pathways 💬, Proximal tubule bicarbonate reclamation 💬, Collecting duct acid secretion 💬, Gastric acid secretion 💬, Pancreatic secretion 💬, Bile secretion 💬 | D07871
D07871
|
Dorzolamide
| 1件: 90 90 |
72 |
CA3
| 2件: Nitrogen metabolism Nitrogen metabolism 💬, Metabolic pathways 💬 | D00218
D00218
|
Acetazolamide
| 8件: 13 13, 86, 90, 115, 154, 155, 225, 230 |
73 |
CA3
| 2件: Nitrogen metabolism Nitrogen metabolism 💬, Metabolic pathways 💬 | D00653
D00653
|
Dorzolamide
| 1件: 90 90 |
74 |
CA3
| 2件: Nitrogen metabolism Nitrogen metabolism 💬, Metabolic pathways 💬 | D01196
D01196
|
Acetazolamide
| 8件: 13 13, 86, 90, 115, 154, 155, 225, 230 |
75 |
CA3
| 2件: Nitrogen metabolism Nitrogen metabolism 💬, Metabolic pathways 💬 | D07871
D07871
|
Dorzolamide
| 1件: 90 90 |
76 |
CA4
| 3件: Nitrogen metabolism Nitrogen metabolism 💬, Metabolic pathways 💬, Proximal tubule bicarbonate reclamation 💬 | D00218
D00218
|
Acetazolamide
| 8件: 13 13, 86, 90, 115, 154, 155, 225, 230 |
77 |
CA4
| 3件: Nitrogen metabolism Nitrogen metabolism 💬, Metabolic pathways 💬, Proximal tubule bicarbonate reclamation 💬 | D00653
D00653
|
Dorzolamide
| 1件: 90 90 |
78 |
CA4
| 3件: Nitrogen metabolism Nitrogen metabolism 💬, Metabolic pathways 💬, Proximal tubule bicarbonate reclamation 💬 | D01196
D01196
|
Acetazolamide
| 8件: 13 13, 86, 90, 115, 154, 155, 225, 230 |
79 |
CA4
| 3件: Nitrogen metabolism Nitrogen metabolism 💬, Metabolic pathways 💬, Proximal tubule bicarbonate reclamation 💬 | D07871
D07871
|
Dorzolamide
| 1件: 90 90 |
80 |
CA5A
| 2件: Nitrogen metabolism Nitrogen metabolism 💬, Metabolic pathways 💬 | D00218
D00218
|
Acetazolamide
| 8件: 13 13, 86, 90, 115, 154, 155, 225, 230 |
81 |
CA5A
| 2件: Nitrogen metabolism Nitrogen metabolism 💬, Metabolic pathways 💬 | D00653
D00653
|
Dorzolamide
| 1件: 90 90 |
82 |
CA5A
| 2件: Nitrogen metabolism Nitrogen metabolism 💬, Metabolic pathways 💬 | D01196
D01196
|
Acetazolamide
| 8件: 13 13, 86, 90, 115, 154, 155, 225, 230 |
83 |
CA5A
| 2件: Nitrogen metabolism Nitrogen metabolism 💬, Metabolic pathways 💬 | D07871
D07871
|
Dorzolamide
| 1件: 90 90 |
84 |
CA6
| 2件: Nitrogen metabolism Nitrogen metabolism 💬, Metabolic pathways 💬 | D00218
D00218
|
Acetazolamide
| 8件: 13 13, 86, 90, 115, 154, 155, 225, 230 |
85 |
CA6
| 2件: Nitrogen metabolism Nitrogen metabolism 💬, Metabolic pathways 💬 | D00653
D00653
|
Dorzolamide
| 1件: 90 90 |
86 |
CA6
| 2件: Nitrogen metabolism Nitrogen metabolism 💬, Metabolic pathways 💬 | D01196
D01196
|
Acetazolamide
| 8件: 13 13, 86, 90, 115, 154, 155, 225, 230 |
87 |
CA6
| 2件: Nitrogen metabolism Nitrogen metabolism 💬, Metabolic pathways 💬 | D07871
D07871
|
Dorzolamide
| 1件: 90 90 |
88 |
CA7
| 2件: Nitrogen metabolism Nitrogen metabolism 💬, Metabolic pathways 💬 | D00218
D00218
|
Acetazolamide
| 8件: 13 13, 86, 90, 115, 154, 155, 225, 230 |
89 |
CA7
| 2件: Nitrogen metabolism Nitrogen metabolism 💬, Metabolic pathways 💬 | D00653
D00653
|
Dorzolamide
| 1件: 90 90 |
90 |
CA7
| 2件: Nitrogen metabolism Nitrogen metabolism 💬, Metabolic pathways 💬 | D01196
D01196
|
Acetazolamide
| 8件: 13 13, 86, 90, 115, 154, 155, 225, 230 |
91 |
CA7
| 2件: Nitrogen metabolism Nitrogen metabolism 💬, Metabolic pathways 💬 | D07871
D07871
|
Dorzolamide
| 1件: 90 90 |
92 |
CA8
| 2件: Nitrogen metabolism Nitrogen metabolism 💬, Metabolic pathways 💬 | D00218
D00218
|
Acetazolamide
| 8件: 13 13, 86, 90, 115, 154, 155, 225, 230 |
93 |
CA8
| 2件: Nitrogen metabolism Nitrogen metabolism 💬, Metabolic pathways 💬 | D00653
D00653
|
Dorzolamide
| 1件: 90 90 |
94 |
CA8
| 2件: Nitrogen metabolism Nitrogen metabolism 💬, Metabolic pathways 💬 | D01196
D01196
|
Acetazolamide
| 8件: 13 13, 86, 90, 115, 154, 155, 225, 230 |
95 |
CA8
| 2件: Nitrogen metabolism Nitrogen metabolism 💬, Metabolic pathways 💬 | D07871
D07871
|
Dorzolamide
| 1件: 90 90 |
96 |
CA9
| 2件: Nitrogen metabolism Nitrogen metabolism 💬, Metabolic pathways 💬 | D00218
D00218
|
Acetazolamide
| 8件: 13 13, 86, 90, 115, 154, 155, 225, 230 |
97 |
CA9
| 2件: Nitrogen metabolism Nitrogen metabolism 💬, Metabolic pathways 💬 | D00653
D00653
|
Dorzolamide
| 1件: 90 90 |
98 |
CA9
| 2件: Nitrogen metabolism Nitrogen metabolism 💬, Metabolic pathways 💬 | D01196
D01196
|
Acetazolamide
| 8件: 13 13, 86, 90, 115, 154, 155, 225, 230 |
99 |
CA9
| 2件: Nitrogen metabolism Nitrogen metabolism 💬, Metabolic pathways 💬 | D07871
D07871
|
Dorzolamide
| 1件: 90 90 |
100 |
CA12
| 2件: Nitrogen metabolism Nitrogen metabolism 💬, Metabolic pathways 💬 | D00218
D00218
|
Acetazolamide
| 8件: 13 13, 86, 90, 115, 154, 155, 225, 230 |
101 |
CA12
| 2件: Nitrogen metabolism Nitrogen metabolism 💬, Metabolic pathways 💬 | D00653
D00653
|
Dorzolamide
| 1件: 90 90 |
102 |
CA12
| 2件: Nitrogen metabolism Nitrogen metabolism 💬, Metabolic pathways 💬 | D01196
D01196
|
Acetazolamide
| 8件: 13 13, 86, 90, 115, 154, 155, 225, 230 |
103 |
CA12
| 2件: Nitrogen metabolism Nitrogen metabolism 💬, Metabolic pathways 💬 | D07871
D07871
|
Dorzolamide
| 1件: 90 90 |
104 |
CACNA1C
| 34件: MAPK signaling pathway MAPK signaling pathway 💬, Calcium signaling pathway 💬, cGMP-PKG signaling pathway 💬, cAMP signaling pathway 💬, Cardiac muscle contraction 💬, Adrenergic signaling in cardiomyocytes 💬, Vascular smooth muscle contraction 💬, Circadian entrainment 💬, Long-term potentiation 💬, Retrograde endocannabinoid signaling 💬, Glutamatergic synapse 💬, Cholinergic synapse 💬, Serotonergic synapse 💬, GABAergic synapse 💬, Dopaminergic synapse 💬, Taste transduction 💬, Insulin secretion 💬, GnRH signaling pathway 💬, Oxytocin signaling pathway 💬, Renin secretion 💬, Aldosterone synthesis and secretion 💬, Cortisol synthesis and secretion 💬, GnRH secretion 💬, Type II diabetes mellitus 💬, Cushing syndrome 💬, Growth hormone synthesis, secretion and action 💬, Alzheimer disease 💬, Prion disease 💬, Pathways of neurodegeneration - multiple diseases 💬, Amphetamine addiction 💬, Chemical carcinogenesis - receptor activation 💬, Hypertrophic cardiomyopathy 💬, Arrhythmogenic right ventricular cardiomyopathy 💬, Dilated cardiomyopathy 💬 | D01908
D01908
|
Nilvadipine
| 1件: 90 90 |
105 |
CACNA1D
| 35件: MAPK signaling pathway MAPK signaling pathway 💬, Calcium signaling pathway 💬, cGMP-PKG signaling pathway 💬, cAMP signaling pathway 💬, Cellular senescence 💬, Cardiac muscle contraction 💬, Adrenergic signaling in cardiomyocytes 💬, Vascular smooth muscle contraction 💬, Tight junction 💬, Circadian entrainment 💬, Retrograde endocannabinoid signaling 💬, Glutamatergic synapse 💬, Cholinergic synapse 💬, Serotonergic synapse 💬, GABAergic synapse 💬, Dopaminergic synapse 💬, Insulin secretion 💬, GnRH signaling pathway 💬, Oxytocin signaling pathway 💬, Renin secretion 💬, Aldosterone synthesis and secretion 💬, Cortisol synthesis and secretion 💬, GnRH secretion 💬, Type II diabetes mellitus 💬, Cushing syndrome 💬, Growth hormone synthesis, secretion and action 💬, Carbohydrate digestion and absorption 💬, Alzheimer disease 💬, Prion disease 💬, Pathways of neurodegeneration - multiple diseases 💬, Amphetamine addiction 💬, Chemical carcinogenesis - receptor activation 💬, Hypertrophic cardiomyopathy 💬, Arrhythmogenic right ventricular cardiomyopathy 💬, Dilated cardiomyopathy 💬 | D01908
D01908
|
Nilvadipine
| 1件: 90 90 |
106 |
CACNA1F
| 27件: MAPK signaling pathway MAPK signaling pathway 💬, Calcium signaling pathway 💬, cGMP-PKG signaling pathway 💬, cAMP signaling pathway 💬, Cardiac muscle contraction 💬, Adrenergic signaling in cardiomyocytes 💬, Vascular smooth muscle contraction 💬, Retrograde endocannabinoid signaling 💬, Cholinergic synapse 💬, Serotonergic synapse 💬, GABAergic synapse 💬, Insulin secretion 💬, GnRH signaling pathway 💬, Oxytocin signaling pathway 💬, Renin secretion 💬, Aldosterone synthesis and secretion 💬, Cortisol synthesis and secretion 💬, GnRH secretion 💬, Cushing syndrome 💬, Growth hormone synthesis, secretion and action 💬, Alzheimer disease 💬, Prion disease 💬, Pathways of neurodegeneration - multiple diseases 💬, Chemical carcinogenesis - receptor activation 💬, Hypertrophic cardiomyopathy 💬, Arrhythmogenic right ventricular cardiomyopathy 💬, Dilated cardiomyopathy 💬 | D01908
D01908
|
Nilvadipine
| 1件: 90 90 |
107 |
CACNA1S
| 27件: MAPK signaling pathway MAPK signaling pathway 💬, Calcium signaling pathway 💬, cGMP-PKG signaling pathway 💬, cAMP signaling pathway 💬, Cardiac muscle contraction 💬, Adrenergic signaling in cardiomyocytes 💬, Vascular smooth muscle contraction 💬, Retrograde endocannabinoid signaling 💬, Cholinergic synapse 💬, Serotonergic synapse 💬, GABAergic synapse 💬, Insulin secretion 💬, GnRH signaling pathway 💬, Oxytocin signaling pathway 💬, Renin secretion 💬, Aldosterone synthesis and secretion 💬, Cortisol synthesis and secretion 💬, GnRH secretion 💬, Cushing syndrome 💬, Growth hormone synthesis, secretion and action 💬, Alzheimer disease 💬, Prion disease 💬, Pathways of neurodegeneration - multiple diseases 💬, Chemical carcinogenesis - receptor activation 💬, Hypertrophic cardiomyopathy 💬, Arrhythmogenic right ventricular cardiomyopathy 💬, Dilated cardiomyopathy 💬 | D01908
D01908
|
Nilvadipine
| 1件: 90 90 |
108 |
ALDH5A1
| 3件: Alanine, aspartate and glutamate metabolism Alanine, aspartate and glutamate metabolism 💬, Butanoate metabolism 💬, Metabolic pathways 💬 | D00399
D00399
|
Valproic acid
| 17件: 2 2, 3, 5, 6, 13, 26, 34, 65, 85, 89, 90, 102, 127, 222, 233, 256, 331 |
109 |
PDE5A
| 3件: Purine metabolism Purine metabolism 💬, Metabolic pathways 💬, cGMP-PKG signaling pathway 💬 | D02229
D02229
|
Sildenafil
| 17件: 6 6, 46, 50, 51, 85, 86, 90, 113, 210, 211, 212, 225, 226, 278, 294, 299, 301 |
110 |
PDE5A
| 3件: Purine metabolism Purine metabolism 💬, Metabolic pathways 💬, cGMP-PKG signaling pathway 💬 | D08514
D08514
|
Sildenafil
| 17件: 6 6, 46, 50, 51, 85, 86, 90, 113, 210, 211, 212, 225, 226, 278, 294, 299, 301 |
111 |
CACNA1I
| 7件: MAPK signaling pathway MAPK signaling pathway 💬, Calcium signaling pathway 💬, Circadian entrainment 💬, Aldosterone synthesis and secretion 💬, Cortisol synthesis and secretion 💬, GnRH secretion 💬, Cushing syndrome 💬 | D00399
D00399
|
Valproic acid
| 17件: 2 2, 3, 5, 6, 13, 26, 34, 65, 85, 89, 90, 102, 127, 222, 233, 256, 331 |
112 |
CACNA1H
| 7件: MAPK signaling pathway MAPK signaling pathway 💬, Calcium signaling pathway 💬, Circadian entrainment 💬, Aldosterone synthesis and secretion 💬, Cortisol synthesis and secretion 💬, GnRH secretion 💬, Cushing syndrome 💬 | D00399
D00399
|
Valproic acid
| 17件: 2 2, 3, 5, 6, 13, 26, 34, 65, 85, 89, 90, 102, 127, 222, 233, 256, 331 |
113 |
CACNA1G
| 8件: MAPK signaling pathway MAPK signaling pathway 💬, Calcium signaling pathway 💬, Circadian entrainment 💬, Aldosterone synthesis and secretion 💬, Cortisol synthesis and secretion 💬, GnRH secretion 💬, Type II diabetes mellitus 💬, Cushing syndrome 💬 | D00399
D00399
|
Valproic acid
| 17件: 2 2, 3, 5, 6, 13, 26, 34, 65, 85, 89, 90, 102, 127, 222, 233, 256, 331 |